Early treatment with sofosbuvir to prevent hcv recurrence after liver transplantation: a case report

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: WANG, Tair Shin (China Taiwan)
  • Co-author(s): Tair Shin Wang
    Ting Yu Wei
    Tzu Hui Yeh
    Shu Hui Sun
  • Abstract:


    We described the case of a 51-year-old male with HCV-related liver cirrhosis. He was prescribed with tacrolimus after live-donor liver transplantation. In order to prevent recurrent HCV genotype 2 infection, HCV treatment was introduced along with sofosbuvir and ribavirin two weeks after liver transplantation with stable liver function.


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login